SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-008540
Filing Date
2022-05-12
Accepted
2022-05-12 16:10:33
Documents
14
Period of Report
2022-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20220511x8k.htm   iXBRL 8-K 43420
2 EX-10.1 agrx-20220511xex10d1.htm EX-10.1 34293
3 EX-99.1 agrx-20220511xex99d1.htm EX-99.1 193225
  Complete submission text file 0001558370-22-008540.txt   416549

Data Files

Seq Description Document Type Size
4 EX-101.SCH agrx-20220511.xsd EX-101.SCH 3181
5 EX-101.LAB agrx-20220511_lab.xml EX-101.LAB 15932
6 EX-101.PRE agrx-20220511_pre.xml EX-101.PRE 10136
8 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20220511x8k_htm.xml XML 4858
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 22917892
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences